Copyright
©The Author(s) 2024.
World J Clin Oncol. Jun 24, 2024; 15(6): 745-754
Published online Jun 24, 2024. doi: 10.5306/wjco.v15.i6.745
Published online Jun 24, 2024. doi: 10.5306/wjco.v15.i6.745
Table 1 Demographic and Clinicopathologic characteristics of United States patients with hepatosplenic T-cell lymphoma between 2000 and 2017
Characteristics | n | % |
Total | 186 | 100 |
Gender | ||
Female | 58 | 31.18 |
Male | 128 | 68.82 |
Age at diagnosis, yr | ||
0-39 | 63 | 33.87 |
40-59 | 67 | 36.02 |
60-79 | 44 | 23.66 |
80+ | 12 | 6.45 |
Race | ||
Non-Hispanic white | 113 | 60.75 |
Non-Hispanic black | 39 | 20.97 |
Hispanic | 15 | 8.06 |
Other | 19 | 10.22 |
Tumor stage | ||
Localized | 44 | 23.66 |
Regional | 13 | 6.99 |
Distant | 129 | 69.35 |
Living area | ||
Counties in metropolitan areas of 1 million persons | 118 | 63.44 |
Counties in metropolitan areas of 250000 to 1 million persons | 38 | 20.43 |
Counties in metropolitan areas of 250000 persons | 17 | 9.14 |
Nonmetropolitan counties | 13 | 6.99 |
Income per year | ||
$ < $55000 | 22 | 11.83 |
$55000-64999 | 33 | 17.74 |
$65000-74999 | 45 | 24.19 |
$75000+ | 86 | 46.24 |
Marital status | ||
Married | 82 | 44.09 |
Single/unknown | 78 | 41.94 |
Divorced/separated | 14 | 7.53 |
Widowed | 12 | 6.45 |
Radiation | ||
No | 173 | 93.01 |
Yes | 13 | 6.99 |
Surgery | ||
No | 116 | 62.37 |
Yes | 70 | 37.63 |
B symptoms | ||
No | 122 | 65.59 |
Yes | 64 | 34.41 |
Year of diagnosis | ||
2000 | 1 | 0.54 |
2001 | 6 | 3.23 |
2002 | 5 | 2.69 |
2003 | 11 | 5.91 |
2004 | 10 | 5.38 |
2005 | 5 | 2.69 |
2006 | 11 | 5.91 |
2007 | 7 | 3.76 |
2008 | 8 | 4.30 |
2009 | 12 | 6.45 |
2010 | 11 | 5.91 |
2011 | 14 | 7.53 |
2012 | 10 | 5.38 |
2013 | 16 | 8.60 |
2014 | 12 | 6.45 |
2015 | 14 | 7.53 |
2016 | 14 | 7.53 |
2017 | 19 | 10.22 |
Table 2 Crude analysis of factors associated with all-cause mortality and hepatosplenic T-cell lymphoma mortality among patients between 2000 and 2017
Characteristics | Overall mortality crude proportional hazard ratio (95% confidence interval) | HSTCL crude proportional hazard ratio (95% confidence interval) |
Gender | ||
Female | 1 (reference) | 1 (reference) |
Male | 0.96 (0.65-1.39) | 0.99 (0.65-1.52) |
Age at diagnosis, yr | ||
0-39 | 1 (reference) | 1 (reference) |
40-59 | 0.80 (0.53-1.22) | 0.69 (0.44-1.11) |
60-79 | 0.95 (0.59-1.54) | 0.85 (0.50-1.45) |
80+ | 1.60 (0.68-3.77) | 1.44 (0.57-3.65) |
Race | ||
Non-Hispanic white | 1 (reference) | 1 (reference) |
Non-Hispanic black | 1.97 (1.27-3.07)b | 2.34 (1.47-3.72)b |
Hispanic | 1.44 (0.71-2.89) | 1.41 (0.64-3.13) |
Other | 1.65 (0.96-2.86) | 1.62 (0.86-3.04) |
Tumor stage | ||
Localized | 1 (reference) | 1 (reference) |
Regional | 1.28 (0.57-2.86) | 1.63 (0.62-4.30) |
Distant | 1.54 (0.97-2.43) | 2.23 (1.24-4.02)b |
Living area | ||
Counties in metropolitan areas of 1 million persons | 1 (reference) | 1 (reference) |
Counties in metropolitan areas of 250000 to 1 million persons | 0.73 (0.46-1.16) | 0.69 (0.41-1.17) |
Counties in metropolitan areas of 250000 persons | 1.19 (0.63-2.24) | 1.02 (0.49-2.12) |
Nonmetropolitan counties | 1.43 (0.76-2.70) | 1.22 (0.59-2.56) |
Income per year | ||
$ < $55000 | 1 (reference) | 1 (reference) |
$55000-64999 | 1.26 (0.65-2.45) | 1.39 (0.65-2.99) |
$65000-74999 | 1.18 (0.63-2.20) | 1.25 (0.59-2.61) |
$75000+ | 0.82 (0.45-1.49) | 1.02 (0.51-2.03) |
Marital status | ||
Married | 1 (reference) | 1 (reference) |
Single/unknown | 1.12 (0.76-1.64) | 1.32 (0.86-2.04) |
Divorced/separated | 1.49 (0.8-2.85) | 1.77 (0.88-3.56) |
Widowed | 1.98 (0.89-4.38) | 1.82 (0.72-4.65) |
Radiation | ||
No | 1 (reference) | 1 (reference) |
Yes | 0.77 (0.37-1.58) | 0.81 (0.38-1.75) |
Surgery | ||
No | 1 (reference) | 1 (reference) |
Yes | 0.76 (0.53-1.09) | 0.72 (0.48-1.09) |
B symptoms | ||
No | 1 (reference) | 1 (reference) |
Yes | 1.23 (0.85-1.80) | 1.14 (0.75-1.75) |
Table 3 Multivariate cox proportional hazard regression analyses of factors affecting all-cause mortality and hepatosplenic T-cell lymphoma related mortality among patients between 2000 and 2017
Characteristics | Overall mortality adjusted proportional hazard ratio (95% confidence interval) | HSTCL adjusted proportional hazard ratio (95% confidence interval) |
Gender | ||
Female | 1 (reference) | 1 (reference) |
Male | 0.79 (0.48-1.29) | 0.83 (0.49-1.41) |
Age at diagnosis, yr | ||
0-39 | 1 (reference) | 1 (reference) |
40-59 | 0.60 (0.32-1.13) | 0.62 (0.30-1.26) |
60-79 | 1.32 (0.67-2.58) | 1.65 (0.78-3.49) |
80+ | 2.98 (0.88-10.09) | 4.72 (1.14-19.54)a |
Race | ||
Non-Hispanic white | 1 (reference) | 1 (reference) |
Non-Hispanic black | 1.61 (0.89-2.89) | 2.02 (1.08-3.79)a |
Hispanic | 1.87 (0.73-4.78) | 1.90 (0.69-5.28) |
Other | 1.59 (0.79-3.19) | 1.49 (0.67-3.37) |
Tumor stage | ||
Localized | 1 (reference) | 1 (reference) |
Regional | 0.69 (0.24-2.01) | 1.17 (0.33-4.19) |
Distant | 1.03 (0.57-1.87) | 1.85 (0.87-3.89) |
Living area | ||
Counties in metropolitan areas of 1 million persons | 1 (reference) | 1 (reference) |
Counties in metropolitan areas of 250,000 to 1 million persons | 1.19 (0.69-2.07) | 1.05 (0.55-2.02) |
Counties in metropolitan areas of 250000 persons | 1.07 (0.44-2.60) | 0.68 (0.24-1.94) |
Nonmetropolitan counties | 2.71 (0.78-9.39) | 2.36 (0.50-11.09) |
Income per year | ||
$ < $55000 | 1 (reference) | 1 (reference) |
$55000-64999 | 2.72 (0.82-9.07) | 2.54 (0.58-11.08) |
$65000-74999 | 1.75 (0.53-5.85) | 1.04 (0.23-4.63) |
$75000+ | 1.46 (0.43-4.96) | 1.23 (0.28-5.53) |
Marital status | ||
Married | 1 (reference) | 1 (reference) |
Single/unknown | 0.83 (0.48-1.44) | 0.94 (0.51-1.75) |
Divorced/separated | 1.33 (0.61-2.90) | 1.79 (0.77-4.19) |
Widowed | 1.19 (0.39-3.62) | 1.01 (0.26-3.87) |
Radiation | ||
No | 1 (reference) | 1 (reference) |
Yes | 0.86 (0.35-2.10) | 1.07 (0.38-3.01) |
Surgery | ||
No | 1 (reference) | 1 (reference) |
Yes | 0.83 (0.49-1.40) | 0.97 (0.54-1.76) |
B symptoms | ||
No | 1 (reference) | 1 (reference) |
Yes | 1.66 (0.85-3.24) | 2.21 (0.99-4.89) |
- Citation: Bangolo A, Fwelo P, Dey S, Sethi T, Sagireddy S, Chatta J, Goel A, Nagpaul S, Chen EPS, Saravanan C, Gangan S, Thomas J, Potiguara S, Nagesh VK, Elias D, Mansour C, Ratnaparkhi PH, Jain P, Mathew M, Porter T, Sultan S, Abbisetty S, Tran L, Chawla M, Lo A, Weissman S, Cho C. Characteristics and distinct prognostic determinants of individuals with hepatosplenic T-cell lymphoma over the past two decades. World J Clin Oncol 2024; 15(6): 745-754
- URL: https://www.wjgnet.com/2218-4333/full/v15/i6/745.htm
- DOI: https://dx.doi.org/10.5306/wjco.v15.i6.745